Loading...
XNYS
PRGO
Market cap1.40bUSD
Aug 03, Last price  
10.68USD
1D
-1.94%
1Q
-15.18%
Jan 2017
-87.85%
Name

Perrigo Company PLC

Chart & performance

D1W1MN
XNYS:PRGO chart
P/E
P/S
0.35
EPS
Div yield, %
11.47%
Shrs. gr., 5y
0.35%
Rev. gr., 5y
0.79%
Revenues
4.25b
-2.75%
1,366,821,0001,447,428,0001,822,131,0002,006,862,0002,268,870,0002,755,029,0003,173,249,0003,539,800,0004,060,800,0004,603,900,0005,280,600,0004,946,200,0004,731,700,0003,869,900,0004,088,200,0004,138,700,0004,451,600,0004,655,600,0004,373,400,0004,253,100,000
Net income
-1.43b
L+729.69%
71,400,00073,797,000135,773,000144,049,000222,546,000339,197,000401,613,000441,900,000205,300,000127,900,000-4,012,800,000119,600,000131,000,000146,100,000-162,600,000-68,900,000-140,600,000-12,700,000-171,800,000-1,425,400,000
CFO
239m
-34.28%
126,531,000128,923,000248,307,000258,345,000314,173,000373,961,000513,376,000553,800,000693,500,0001,198,300,000654,900,000698,900,000593,000,000387,800,000636,200,000156,300,000307,300,000405,500,000362,900,000238,500,000
Dividend
Aug 28, 20260.29 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
IPO date
Dec 17, 1991
Employees
8,900
Domiciled in
IE
Incorporated in
IE

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT